<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">A Sasse</style></author><author><style face="normal" font="default" size="100%">Florence, E</style></author><author><style face="normal" font="default" size="100%">Pharris, A</style></author><author><style face="normal" font="default" size="100%">De Wit, S</style></author><author><style face="normal" font="default" size="100%">Lacor, P</style></author><author><style face="normal" font="default" size="100%">Dominique Van Beckhoven</style></author><author><style face="normal" font="default" size="100%">Jessika Deblonde</style></author><author><style face="normal" font="default" size="100%">Delforge, M-L</style></author><author><style face="normal" font="default" size="100%">Fransen, K</style></author><author><style face="normal" font="default" size="100%">Goffard, J-C</style></author><author><style face="normal" font="default" size="100%">Legrand, J-C</style></author><author><style face="normal" font="default" size="100%">Moutschen, M</style></author><author><style face="normal" font="default" size="100%">Piérard, D</style></author><author><style face="normal" font="default" size="100%">Ruelle, J</style></author><author><style face="normal" font="default" size="100%">Vaira, D</style></author><author><style face="normal" font="default" size="100%">Vandercam, B</style></author><author><style face="normal" font="default" size="100%">Van Ranst, M</style></author><author><style face="normal" font="default" size="100%">Van Wijngaerden, E</style></author><author><style face="normal" font="default" size="100%">Vandekerckhove, L</style></author><author><style face="normal" font="default" size="100%">Verhofstede, C</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">Belgian Research AIDS &amp; HIV Consortium (BREACH)</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Late presentation to HIV testing is overestimated when based on the consensus definition.</style></title><secondary-title><style face="normal" font="default" size="100%">HIV Med</style></secondary-title><alt-title><style face="normal" font="default" size="100%">HIV Med</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">CD4 Lymphocyte Count</style></keyword><keyword><style  face="normal" font="default" size="100%">Consensus</style></keyword><keyword><style  face="normal" font="default" size="100%">Delayed Diagnosis</style></keyword><keyword><style  face="normal" font="default" size="100%">HIV Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">Homosexuality, Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2016 Mar</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">231-4</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;b&gt;OBJECTIVES: &lt;/b&gt;In 2011, a consensus was reached defining &quot;late presenters&quot; (LPs) as individuals presenting for care with a CD4 count &lt; 350 cells/μL or with an AIDS-defining event, regardless of CD4 count. However, a transient low CD4 count is not uncommon in recent infections. The objective of this study was to investigate how measurements of late presentation change if the clinical stage at the time of diagnosis is taken into account.&lt;/p&gt;&lt;p&gt;&lt;b&gt;METHODS: &lt;/b&gt;Case surveillance data for newly diagnosed patients in Belgium in 1998-2012 were analysed, including CD4 count at diagnosis, the presence of AIDS-defining events, and recent infections (&lt; 6 months) as reported by clinicians in the case of acute illness or a recent negative test. First, proportions of LPs were calculated according to the consensus definition. Secondly, LPs were reclassified as &quot;nonlate&quot; if infections were reported as recent.&lt;/p&gt;&lt;p&gt;&lt;b&gt;RESULTS: &lt;/b&gt;A total of 7949 HIV diagnoses were included in the study. Recent infections were increasingly reported over time, accounting for 8.2% of new infections in 1998 and 37.5% in 2012. The consideration of clinical stage significantly modified the proportion of LPs: 18.2% of men who have sex with men (MSM) diagnosed in 2012 would be classified as LPs instead of 30.9% using the consensus definition (P &lt; 0.001). The proportion of patients misclassified as LPs increased significantly over time: 5% in MSM in 1998 vs. 41% in 2012.&lt;/p&gt;&lt;p&gt;&lt;b&gt;CONCLUSIONS: &lt;/b&gt;This study suggests that low CD4 counts in recent infections may lead to overestimation of late presentation when applying the consensus definition. The impact of transient CD4 count on late presentation estimates should be assessed and, if relevant, the introduction of clinical stage in the definition of late presentation should be considered.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><custom1><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26222266?dopt=Abstract</style></custom1></record></records></xml>